Ebook for Directors in Clinical Trials

Ultimate Guide on Open Source for Clinical Trial Leaders

Explore how open-source technology – particularly R and Shiny is transforming clinical trials and the broader pharmaceutical industry.

Get the Ebook

Download the Ebook

Get Your Copy Today

Name*

Business Email*

Phone Number

You may unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.

What’s Inside

Distilled Expertise from Years of Open-source Innovation in Clinical Trials

Your shortcut to faster, smarter pharma innovation that drives business impact and reshapes healthcare.

Expert Guidance

Combined knowledge from Appsilon’s engineers and partners, gathered through years of collaboration with leading pharmaceutical companies.

Real-World Examples

Detailed insights into how innovators like Roche, Novartis, and Novo Nordisk are adopting open-source solutions in clinical research.

Future Trends

Expert perspectives on key directions and innovations driving technology transformation across the pharmaceutical industry.

Actionable Guidelines

Proven recommendations shaped through implementing modern tools
in computing environments.

Who Should Read This Ebook?

Download the Ebook

Clinical Trial
Directors

If you're responsible for trial oversight, this guide will show you how open-source tools can cut reporting time, reduce costs, and ensure compliance with evolving standards.

Pharma IT
& Data Leads

For those managing infrastructure, tooling, and analytics – learn how R, Shiny, and modern engineering practices streamline workflows and scale across global teams.

Regulatory
& Compliance Teams

Gain insights into how open-source platforms meet strict regulatory requirements while improving transparency, reproducibility, and audit readiness in clinical research.

Expert’s Perspective

"It’s been a long journey for us, but we’re now making serious investments to establish some of our open-source tools as the de facto standard in pharma."

Ari Siggaard Knoph

Principal Clinical Data Scientist & Global Project Lead at Novo Nordisk A/S

See What We Can Do for You

Don’t Reinvent the Wheel

Many companies have already pioneered open-source adoption in drug development. Leverage their progress instead of starting from scratch. Through collaboration and open innovation, we can drive greater impact together.

Download the Ebook

01.

The Future of Drug Development Is Open Source

Learn about common SAS limitations and debunk open-source myths. Discover why open-source tools are transforming reporting and data analysis helping pharma companies to deliver projects faster while navigating corporate policies and team dynamics.

02.

How Open Source Enhances the Drug Development Process

Explore how modern technologies empower researchers across every stage of drug development,— from discovery and clinical trials to manufacturing, distribution, and pharmacovigilance. Gain actionable insights from real-world case studies.

03.

Transforming to Open Source: Tips and Recommendations

Proven strategies for modernizing your computing environments. Leverage battle-tested expertise and lessons learned from collaborating with pharma leaders on scalable, secure solutions.